Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
DILTIAZEM MALATE
(1996)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Unknown
DILTIAZEM MALATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
14Y6444DRP
Molecule Type:
Small molecule
Molecular Formula:
C26H32N2O9S
Molecular Weight:
548.61
AlogP:
3.37
PSA:
59.08
HBD:
0.0
HBA:
#RotB:
6.0
Source:
DONEPEZIL
(1996)
Small molecule
Unknown
Unknown
Approved
Dementia
DONEPEZIL
×
Maximum Phase:
4
First Approval:
1996
UNII:
8SSC91326P
Molecule Type:
Small molecule
Molecular Formula:
C24H29NO3
Molecular Weight:
379.5
AlogP:
4.36
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
6.0
Source:
MIGLITOL
(1996)
Small molecule
Lysosomal alpha-glucosidase inhibitor
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
MIGLITOL
×
Maximum Phase:
4
First Approval:
1996
UNII:
0V5436JAQW
Molecule Type:
Small molecule
Molecular Formula:
C8H17NO5
Molecular Weight:
207.23
AlogP:
-3.26
PSA:
104.39
HBD:
5.0
HBA:
#RotB:
3.0
Source:
GEMCITABINE HYDROCHLORIDE
(1996)
Small molecule
DNA polymerase (alpha/delta/epsilon) inhibitor
INJECTION; INTRAVENOUS
Approved
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Pancreatic Neoplasms
GEMCITABINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
U347PV74IL
Molecule Type:
Small molecule
Molecular Formula:
C9H12ClF2N3O4
Molecular Weight:
299.66
AlogP:
-1.29
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
2.0
Source:
FOSFOMYCIN
(1996)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
FOSFOMYCIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
2N81MY12TE
Molecule Type:
Small molecule
Molecular Formula:
C3H7O4P
Molecular Weight:
138.06
AlogP:
-0.09
PSA:
70.06
HBD:
2.0
HBA:
#RotB:
1.0
Source:
NEVIRAPINE
(1996)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Approved
HIV Infections; Virus Diseases
NEVIRAPINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
99DK7FVK1H
Molecule Type:
Small molecule
Molecular Formula:
C15H14N4O
Molecular Weight:
266.3
AlogP:
2.65
PSA:
58.12
HBD:
1.0
HBA:
#RotB:
1.0
Source:
UREA
(1996)
Small molecule
Unknown
INJECTION
Approved
Unknown
UREA
×
Maximum Phase:
4
First Approval:
1996
UNII:
8W8T17847W
Molecule Type:
Small molecule
Molecular Formula:
CH4N2O
Molecular Weight:
60.06
AlogP:
-0.98
PSA:
69.11
HBD:
2.0
HBA:
#RotB:
0.0
Source:
MEROPENEM
(1996)
Small molecule
Bacterial penicillin-binding protein inhibitor
INJECTION; INTRAVENOUS
Approved
Bacteremia; Bacterial Infections; Infections; Intraabdominal Infections; Meningitis; Meningitis, Bacterial; Urinary Tract Infections
MEROPENEM
×
Maximum Phase:
4
First Approval:
1996
UNII:
FV9J3JU8B1
Molecule Type:
Small molecule
Molecular Formula:
C17H25N3O5S
Molecular Weight:
383.47
AlogP:
-0.31
PSA:
110.18
HBD:
3.0
HBA:
#RotB:
5.0
Source:
PENTOSAN POLYSULFATE SODIUM
(1996)
Small molecule
Unknown
ORAL
Approved
Unknown
PENTOSAN POLYSULFATE SODIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
914032762Y
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLATIRAMER ACETATE
(1996)
Small molecule
Unknown
SUBCUTANEOUS
Approved
Unknown
GLATIRAMER ACETATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
5M691HL4BO
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMLEXANOX
(1996)
Small molecule
Phosphodiesterase 4 inhibitor
DENTAL; TOPICAL
Approved
Lung Diseases, Obstructive
AMLEXANOX
×
Maximum Phase:
4
First Approval:
1996
UNII:
BRL1C2459K
Molecule Type:
Small molecule
Molecular Formula:
C16H14N2O4
Molecular Weight:
298.3
AlogP:
2.75
PSA:
106.42
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PHENYLBUTANOIC ACID
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
PHENYLBUTANOIC ACID
×
Maximum Phase:
4
First Approval:
1996
UNII:
7WY7YBI87E
Molecule Type:
Small molecule
Molecular Formula:
C10H12O2
Molecular Weight:
164.2
AlogP:
2.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ALLOPURINOL SODIUM
(1996)
Small molecule
Xanthine dehydrogenase inhibitor
INJECTION
Approved
Unknown
ALLOPURINOL SODIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
428673RC2Z
Molecule Type:
Small molecule
Molecular Formula:
C5H3N4NaO
Molecular Weight:
158.1
AlogP:
-0.4
PSA:
74.43
HBD:
2.0
HBA:
#RotB:
0.0
Source:
PENCICLOVIR
(1996)
Small molecule
Human herpesvirus 1 DNA polymerase inhibitor
TOPICAL
Approved
Herpes Labialis; Virus Diseases
PENCICLOVIR
×
Maximum Phase:
4
First Approval:
1996
UNII:
359HUE8FJC
Molecule Type:
Small molecule
Molecular Formula:
C10H15N5O3
Molecular Weight:
253.26
AlogP:
-0.9
PSA:
130.31
HBD:
4.0
HBA:
#RotB:
5.0
Source:
CIDOFOVIR
(1996)
Small molecule
Human herpesvirus 1 DNA polymerase inhibitor
INJECTION
Approved
Cytomegalovirus Retinitis; Primary Immunodeficiency Diseases; Virus Diseases
CIDOFOVIR
×
Maximum Phase:
4
First Approval:
1996
UNII:
JIL713Q00N
Molecule Type:
Small molecule
Molecular Formula:
C8H14N3O6P
Molecular Weight:
279.19
AlogP:
-1.66
PSA:
147.9
HBD:
4.0
HBA:
#RotB:
6.0
Source:
OLOPATADINE
(1996)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations; Nasal Obstruction
OLOPATADINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
D27V6190PM
Molecule Type:
Small molecule
Molecular Formula:
C21H23NO3
Molecular Weight:
337.42
AlogP:
3.59
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ROPIVACAINE
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
ROPIVACAINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
7IO5LYA57N
Molecule Type:
Small molecule
Molecular Formula:
C17H26N2O
Molecular Weight:
274.41
AlogP:
3.51
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TECHNETIUM TC 99M TETROFOSMIN
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
TECHNETIUM TC 99M TETROFOSMIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
42FOP1YX93
Molecule Type:
Small molecule
Molecular Formula:
C18H40O4P2Tc
Molecular Weight:
481.37
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TRANDOLAPRIL
(1996)
Small molecule
Angiotensin-converting enzyme inhibitor
ORAL
Approved
Cardiovascular Diseases; Heart Failure; Hypertension; Myocardial Infarction; Ventricular Dysfunction, Left
TRANDOLAPRIL
×
Maximum Phase:
4
First Approval:
1996
UNII:
1T0N3G9CRC
Molecule Type:
Small molecule
Molecular Formula:
C24H34N2O5
Molecular Weight:
430.55
AlogP:
2.77
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
BETAINE
(1996)
Small molecule
Betaine-homocysteine S-methyltransferase substrate
ORAL
Approved
Depressive Disorder; Homocystinuria
BETAINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
3SCV180C9W
Molecule Type:
Small molecule
Molecular Formula:
C5H12NO2+
Molecular Weight:
118.16
AlogP:
-0.22
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BISMUTH SUBSALICYLATE
(1996)
Small molecule
Cyclooxygenase inhibitor
Unknown
Approved
Unknown
BISMUTH SUBSALICYLATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
62TEY51RR1
Molecule Type:
Small molecule
Molecular Formula:
C7H5BiO4
Molecular Weight:
362.09
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ATORVASTATIN CALCIUM
(1996)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Angina Pectoris; Angina, Stable; Coronary Artery Disease; Dyslipidemias; Heart Failure; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypertension; Myocardial Infarction; Stroke
ATORVASTATIN CALCIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
48A5M73Z4Q
Molecule Type:
Small molecule
Molecular Formula:
C66H68CaF2N4O10
Molecular Weight:
1155.36
AlogP:
6.31
PSA:
111.79
HBD:
4.0
HBA:
#RotB:
12.0
Source:
TIZANIDINE HYDROCHLORIDE
(1996)
Small molecule
Adrenergic receptor alpha-2 agonist
ORAL
Approved
Muscle Spasticity
TIZANIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
B53E3NMY5C
Molecule Type:
Small molecule
Molecular Formula:
C9H9Cl2N5S
Molecular Weight:
290.18
AlogP:
1.72
PSA:
62.2
HBD:
2.0
HBA:
#RotB:
1.0
Source:
TECHNETIUM TETROFOSMIN
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
TECHNETIUM TETROFOSMIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C18H40O4P2Tc
Molecular Weight:
480.46
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MANGAFODIPIR
(1997)
Small molecule
Diagnostic
Unknown
Approved
Unknown
MANGAFODIPIR
×
Maximum Phase:
4
First Approval:
1997
UNII:
N02W67RKJS
Molecule Type:
Small molecule
Molecular Formula:
C22H30MnN4O14P2
Molecular Weight:
691.38
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MIBEFRADIL
(1997)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
MIBEFRADIL
×
Maximum Phase:
4
First Approval:
1997
UNII:
27B90X776A
Molecule Type:
Small molecule
Molecular Formula:
C29H38FN3O3
Molecular Weight:
495.64
AlogP:
5.27
PSA:
67.45
HBD:
1.0
HBA:
#RotB:
11.0
Source:
FENOLDOPAM MESYLATE
(1997)
Small molecule
Dopamine D1 receptor agonist
Unknown
Approved
Hypertension
FENOLDOPAM MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
HA3R0MY016
Molecule Type:
Small molecule
Molecular Formula:
C17H20ClNO6S
Molecular Weight:
401.87
AlogP:
2.73
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
1.0
Source:
SAMARIUM SM 153 LEXIDRONAM PENTASODIUM
(1997)
Small molecule
Unknown
Unknown
Approved
Unknown
SAMARIUM SM 153 LEXIDRONAM PENTASODIUM
×
Maximum Phase:
4
First Approval:
1997
UNII:
7389YR3OOV
Molecule Type:
Small molecule
Molecular Formula:
C6H12N2Na5O12P4Sm
Molecular Weight:
695.93
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
IMIQUIMOD
(1997)
Small molecule
Toll-like receptor 7 agonist
TOPICAL
Approved
Carcinoma, Basal Cell; Keratosis, Actinic; Virus Diseases
IMIQUIMOD
×
Maximum Phase:
4
First Approval:
1997
UNII:
P1QW714R7M
Molecule Type:
Small molecule
Molecular Formula:
C14H16N4
Molecular Weight:
240.31
AlogP:
2.82
PSA:
56.73
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TILUDRONIC ACID
(1997)
Small molecule
Unknown
Unknown
Approved
Bone Diseases
TILUDRONIC ACID
×
Maximum Phase:
4
First Approval:
1997
UNII:
6PNS59HP4Y
Molecule Type:
Small molecule
Molecular Formula:
C7H9ClO6P2S
Molecular Weight:
318.61
AlogP:
2.07
PSA:
115.06
HBD:
4.0
HBA:
#RotB:
4.0
Source:
SAMARIUM LEXIDRONAM PENTASODIUM
(1997)
Small molecule
Unknown
Unknown
Approved
Unknown
SAMARIUM LEXIDRONAM PENTASODIUM
×
Maximum Phase:
4
First Approval:
1997
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C6H12N2Na5O12P4Sm
Molecular Weight:
693.37
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SIBUTRAMINE HYDROCHLORIDE
(1997)
Small molecule
Monoamine transporter inhibitor
ORAL
Approved
Unknown
SIBUTRAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
OGM0YHD1WF
Molecule Type:
Small molecule
Molecular Formula:
C17H29Cl2NO
Molecular Weight:
334.33
AlogP:
4.74
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
5.0
Source:
CERIVASTATIN SODIUM
(1997)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Unknown
CERIVASTATIN SODIUM
×
Maximum Phase:
4
First Approval:
1997
UNII:
6Q18G1060S
Molecule Type:
Small molecule
Molecular Formula:
C26H33FNNaO5
Molecular Weight:
481.54
AlogP:
4.88
PSA:
99.88
HBD:
3.0
HBA:
#RotB:
11.0
Source:
FERRIC AMMONIUM CITRATE
(1997)
Small molecule
Unknown
ORAL
Approved
Unknown
FERRIC AMMONIUM CITRATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
UVP74NG1C5
Molecule Type:
Small molecule
Molecular Formula:
C6H8FeNO7
Molecular Weight:
261.98
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FENOLDOPAM
(1997)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
FENOLDOPAM
×
Maximum Phase:
4
First Approval:
1997
UNII:
INU8H2KAWG
Molecule Type:
Small molecule
Molecular Formula:
C16H16ClNO3
Molecular Weight:
305.76
AlogP:
2.73
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
1.0
Source:
HYDROCORTISONE PROBUTATE
(1997)
Small molecule
Glucocorticoid receptor agonist
TOPICAL
Approved
Adrenal Hyperplasia, Congenital; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Asthma; Bursitis; Colitis, Ulcerative; Conjunctivitis, Allergic; Dermatitis; Dermatitis, Atopic; Dermatitis, Seborrheic; Endocrine System Diseases; Exanthema; Inflammation; Leukemia; Lymphoma; Neoplasms; Osteoarthritis; Pruritus; Psoriasis; Serum Sickness; Skin Diseases; Spondylitis; Tenosynovitis
HYDROCORTISONE PROBUTATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
O6550D6K3A
Molecule Type:
Small molecule
Molecular Formula:
C28H40O7
Molecular Weight:
488.62
AlogP:
4.09
PSA:
106.97
HBD:
1.0
HBA:
#RotB:
7.0
Source:
1
2
…
45
46
47
48
49
50
51
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA